155 related articles for article (PubMed ID: 19227298)
1. [Albumin dialysis (MARS therapy) in patients with hepatic graft dysfunction].
Aleksandrova IV; Ermolov AS; Chzhao AV; Artamonov VV; Reĭ SI
Anesteziol Reanimatol; 2008; (6):67-70. PubMed ID: 19227298
[TBL] [Abstract][Full Text] [Related]
2. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Löhr JM; Liebe S; Emmrich J; Korten G; Schmidt R
Liver Transpl; 2000 May; 6(3):277-86. PubMed ID: 10827226
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis.
Bellmann R; Graziadei IW; Feistritzer C; Schwaighofer H; Stellaard F; Sturm E; Wiedermann CJ; Joannidis M
Liver Transpl; 2004 Jan; 10(1):107-14. PubMed ID: 14755786
[TBL] [Abstract][Full Text] [Related]
4. [Role and place of albumin dialysis in the treatment of patients with hepatic insufficiency].
Kutepov DE; Pasechnik IN; Popov AV; Kontarev SI; Krylov VV
Anesteziol Reanimatol; 2010; (2):53-8. PubMed ID: 20524334
[TBL] [Abstract][Full Text] [Related]
5. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
[TBL] [Abstract][Full Text] [Related]
7. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
[TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis in primary dysfunction of hepatic transplants.
Skerrett D; Mor E; Curtiss S; Mohandas K
J Clin Apher; 1996; 11(1):10-3. PubMed ID: 8722715
[TBL] [Abstract][Full Text] [Related]
9. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers.
Parés A; Herrera M; Avilés J; Sanz M; Mas A
J Hepatol; 2010 Aug; 53(2):307-12. PubMed ID: 20580987
[TBL] [Abstract][Full Text] [Related]
10. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
[TBL] [Abstract][Full Text] [Related]
11. Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation.
Santise G; D'Ancona G; Falletta C; Pirone F; Sciacca S; Turrisi M; Biondo D; Pilato M
Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):476-9. PubMed ID: 19564203
[TBL] [Abstract][Full Text] [Related]
12. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease.
Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R
Liver Transpl; 2002 Oct; 8(10):962-7. PubMed ID: 12360442
[TBL] [Abstract][Full Text] [Related]
13. Primary nonfunction: timing retransplantation versus hemodynamic parameters and kidney function.
Novelli G; Rossi M; Poli L; Morabito V; Bussotti A; Pugliese F; Ruberto F; Novelli S; Mennini G; Berloco PB
Transplant Proc; 2008; 40(6):1854-7. PubMed ID: 18675069
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis.
Javouhey E; Ranchin B; Lachaux A; Boillot O; Martin X; Floret D; Cochat P
Pediatr Transplant; 2009 Mar; 13(2):235-9. PubMed ID: 18433409
[TBL] [Abstract][Full Text] [Related]
15. The clinical relevance of the anhepatic phase during liver transplantation.
Ijtsma AJ; van der Hilst CS; de Boer MT; de Jong KP; Peeters PM; Porte RJ; Slooff MJ
Liver Transpl; 2009 Sep; 15(9):1050-5. PubMed ID: 19718649
[TBL] [Abstract][Full Text] [Related]
16. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.
Sen S; Mookerjee RP; Cheshire LM; Davies NA; Williams R; Jalan R
J Hepatol; 2005 Jul; 43(1):142-8. PubMed ID: 15878216
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the molecular adsorbent recirculating system and plasmapheresis for patients with graft dysfunction after liver transplantation.
Lee JY; Kim SB; Chang JW; Park SK; Kwon SW; Song KW; Hwang S; Lee SG
Transplant Proc; 2010 Sep; 42(7):2625-30. PubMed ID: 20832557
[TBL] [Abstract][Full Text] [Related]
18. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis.
Kortgen A; Rauchfuss F; Götz M; Settmacher U; Bauer M; Sponholz C
Ther Apher Dial; 2009 Oct; 13(5):419-25. PubMed ID: 19788459
[TBL] [Abstract][Full Text] [Related]
19. Treatment of split-liver recipients with poor graft function by albumin-dialysis (Mars).
Loock J; Treichel U; Gerken G; Malago M; Broelsch C; Philipp T; Heemann U
Z Gastroenterol; 2001 Jun; 39 Suppl 2():18-9. PubMed ID: 16215888
[No Abstract] [Full Text] [Related]
20. [Replacement therapy for hepatic failure syndrome].
Iampol'skiĭ AF; Eremeeva LF
Anesteziol Reanimatol; 2006; (6):26-30. PubMed ID: 17288262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
